Zhejiang HISUN Biomaterials Co. Ltd. A Total Liabilities
Zhejiang HISUN Biomaterials Co. Ltd. A total liabilities. Based on the latest financial reports, Zhejiang HISUN Biomaterials Co. Ltd. A (688203) has total liabilities worth CN¥542.63 Million CNY (≈ $79.40 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Zhejiang HISUN Biomaterials Co. Ltd. A liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)
Total liabilities of Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024. This chart illustrates how Zhejiang HISUN Biomaterials Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data.
Zhejiang HISUN Biomaterials Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Zhejiang HISUN Biomaterials Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kambi Group PLC Series B
IL:0EAW
|
UK | Skr33.48 Million |
|
Citizens & Northern Corp
NASDAQ:CZNC
|
USA | $2.81 Billion |
|
Hume Industries Berhad
KLSE:5000
|
Malaysia | RM329.57 Million |
|
China Haisum Engineering Co Ltd
SHE:002116
|
China | CN¥3.11 Billion |
|
CanSino Biologics Inc
F:CJH
|
Germany | €2.22 Billion |
|
Shakti Pumps (India) Limited
NSE:SHAKTIPUMP
|
India | Rs-17.06 Billion |
|
BlackRock Core Bond Closed Fund
NYSE:BHK
|
USA | $346.00 Million |
|
Harbin Medisan Pharmaceutical Co Ltd
SHE:002900
|
China | CN¥1.70 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Zhejiang HISUN Biomaterials Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Zhejiang HISUN Biomaterials Co. Ltd. A's balance sheet.
Liquidity & Leverage Metrics
Zhejiang HISUN Biomaterials Co. Ltd. A Total Liabilities Ratios Explained
Zhejiang HISUN Biomaterials Co. Ltd. A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang HISUN Biomaterials Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)
The table below shows the annual total liabilities of Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥574.05 Million ≈ $84.00 Million |
+0.84% |
| 2023-12-31 | CN¥569.25 Million ≈ $83.30 Million |
+19.45% |
| 2022-12-31 | CN¥476.56 Million ≈ $69.74 Million |
-9.96% |
| 2021-12-31 | CN¥529.26 Million ≈ $77.45 Million |
-4.70% |
| 2020-12-31 | CN¥555.36 Million ≈ $81.27 Million |
-- |
About Zhejiang HISUN Biomaterials Co. Ltd. A
Zhejiang Hisun Biomaterials Co.Ltd. engages in the research, development, production, and sale of polylactic acid in China. The company's products are used in various applications that include 3D printing, extrusion, thermoforming, film and laminating, injection molding, non-woven fabric, and injection blow molding. Zhejiang Hisun Biomaterials Co.Ltd. was founded in 2004 and is based in Taizhou, … Read more